Nils-Petter Rudqvist, Ph.D.
Department of Thoracic-Head & Neck Med Onc, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
TimIOs Team Lead, Society for Immunotherapy of Cancer, Milwaukee, WI
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Radiation Oncology, Weill Cornell Medicine, New York, NY
Regular Member, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX
Education & Training
Degree-Granting Education
| 2015 | University of Gothenburg, Gothenburg, SWE, PHD, Medical Science |
| 2009 | University of Gothenburg, Gothenburg, SWE, MS, Physics |
Postgraduate Training
| 2016-2020 | Postdoctoral Associate, Radiation Oncology, Weill Cornell Medicine, New York, NY |
| 2015-2016 | Postdoctoral Researcher, Radiation Sciences, Columbia University Medical Center, New York, NY |
Experience & Service
Other Appointments/Responsibilities
Member of University Board of Directors, University of Gothenburg, Gothenburg, 2013 - 2014
President of the Doctoral Committee, University of Gothenburg, Gothenburg, 2012 - 2013
Institutional Committee Activities
Member, Academic Leadership Team, 2020 - Present
Honors & Awards
| 2021 | Team Science Award, Society for Immunotherapy of Cancer |
| 2020 | Presidential Travel Award, Society for Immunotherapy of Cancer |
| 2019 | Young Investigator Researcher Award, Society for Immunotherapy of Cancer |
| 2017 | Marie Curie Award, Radiation Research Society |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Wennerberg E, Spada S, Rudqvist N, Lhuillier C, Gruber S, Chen Q, Zhang F, Zhou XK, Gross SS, Formenti SC, Demaria S. CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. Cancer Immunol Res 8(4):465-478, 2020. e-Pub 2020. PMID: 32047024.
- Wennerberg E, Lhuillier C, Rybstein MD, Dannenberg K, Rudqvist NP, Koelwyn GJ, Jones LW, Demaria S. Exercise reduces immune suppression and breast cancer progression in a preclinical model. Oncotarget 11(4):452-461, 2020. e-Pub 2020. PMID: 32064049.
- Lhuillier C, Rudqvist NP, Elemento O, Formenti SC, Demaria S. Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system. Genome Med 11(1):40, 2019. e-Pub 2019. PMID: 31221199.
- Vitale I, Sistigu A, Manic G, Rudqvist NP Trajanoski Z, Galluzzi L. Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. Trends Cell Biol 29(5):396-416, 2019. e-Pub 2019. PMID: 30765144.
- Formenti SC, Rudqvist NP, Golden E, Cooper B, Wennerberg E, Lhuillier C, Vanpouille-Box C, Friedman K, Ferrari de Andrade L, Wucherpfennig KW, Heguy A, Imai N, Gnjatic S, Emerson RO, Zhou XK, Zhang T, Chachoua A, Demaria S. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med 24(12):1845-1851, 2018. e-Pub 2018. PMID: 30397353.
- Diamond JM, Vanpouille-Box C, Spada S, Rudqvist NP, Chapman JR, Ueberheide BM, Pilones KA, Sarfraz Y, Formenti SC, Demaria S. Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs. Cancer Immunol Res 6(8):910-920, 2018. e-Pub 2018. PMID: 29907693.
- Rudqvist N, Pilones KA, Lhuillier C, Wennerberg E, Sidhom JW, Emerson RO, Robins HS, Schneck J, Formenti SC, Demaria S. Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells. Cancer Immunol Res 6(2):139-150, 2018. e-Pub 2017. PMID: 29180535.
- Wennerberg E, Lhuillier C, Vanpouille-Box C, Pilones KA, García-Martínez E, Rudqvist NP, Formenti SC, Demaria S. Barriers to Radiation-Induced In Situ Tumor Vaccination. Front Immunol 8:229, 2017. e-Pub 2017. PMID: 28348554.